TrialJournal of translational medicine2013

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.

Pawan K Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.